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Table I. Oligonucleotide primers used in PCR test for HPV DNA
Primers Amplified region DNA Map position Sequence 59 – 39 Length of product
CGTCCMARRGGAWACTGATC
MY09 LI33 types 1 GCMCAGGGWCATAAYAATGG 450 bp
M 5 A 1 C, R 5 A 1 G, W 5 A 1 T, Y 5 C 1 T
MY11 HPV –
PC03 β-globin 1 62202–62221 ACACAACTGGTTTCACTAGC
PC04 gene – 62292–62311 CAACTTCATCCACGTTCACC 110 bp
Table II. Results of analysis for the presence of HPV DNA sequences in DNA isolated in blood and the lesions in
individual groups
Studied Sex Number Verruceous lesions HPV in lesions Blood
group of patients
1 – 1 – HPV1 HPV–
Condyloma F 6 2 4 2 – 6 0
acuminata M 6 5 1 5 – 5 1
Common F 2 2 – 2 – 0 2
warts M 4 4 – 4 – 0 4
Blood F 6 – 6 – – 0 6
donors M 6 – 6 – – 0 6
hybridization and polymerase chain reaction. The techniques are
particularly useful in the analysis of virus DNA sequences in cells
of various tissues. Until now, polymerase chain reaction allowed
the presence of HPV to be detected not only in epidermal warts,
but also in the unchanged mucous membranes of sexual organs and
of the mouth cavity, which proves the potential for latent HPV
infections.
On the basis of the obtained results in patients with persisting
condyloma acuminata, it has been shown that their blood also
contains HPV. This indicates that HPV may become transferred to
other sites in the human body; however, the failure to detect HPV
DNA sequences in one of the males who is a sexual partner of an
HPV infected patient, indicates that the process is controlled by
additional factors. Moreover, some forms of sexual relations may
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To the Editor:
Atopic dermatitis (AD) has been shown to be frequently colonized
by Staphylococcus aureus (Leyden et al, 1974; Aly et al, 1977).
Staphylococcus aureus could be successfully cultured from lesional and
from nonlesional skin of acute and chronic stages of AD (Monti
et al, 1996). These findings supported the idea of a cause and effect
relationship between S. aureus and AD (Wakita et al, 1995). Further
evidence was provided by S. aureus being reported to be capable
of forming superantigens (McFadden et al, 1993; Cooper, 1994;
Wakita et al, 1995; Strange et al, 1996; Yudate et al, 1996). Some
doubt about the role of S. aureus arose when it was demonstrated
that corticosteroids (Nilsson et al, 1992) were capable of significantly
improving AD and decreasing skin colonization by S. aureus.
Furthermore, only a few investigations were carried out to detect
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cause a predisposition for infection with the virus through
various pathways.
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S. aureus colonization in the nasal mucosa as a possible reservoir
for skin colonization. Therefore, we studied a group of AD patients
for the presence of S. aureus on the lesional skin as well as for
colonization of the vestibulum nasi. The isolates were investigated
for superantigen genetic determinants and in vitro production. In
order to answer the question of whether S. aureus from AD patients
form a special subgroup of staphylococci, as is the case for S. aureus
capable of producing toxic shock syndrome toxin 1 (TSST-1) or
exfoliative toxins (Johnson et al, 1991), we subjected these strains
to molecular population analysis and compared them with S. aureus
from nasal colonization of healthy humans. Colonization of skin
and anterior nares by S. aureus was studied in 35 patients, aged
3 mo to 53 y, with different stages of AD, and in a group of
healthy students. Sixty students were investigated concerning nasal
colonization, and 20 of 60 were additionally checked for skin
colonization. Twenty-two of 35 patients showed acute exacerbation
of AD at the time of admission. They had not received antibiotics
during the last 6 mo and were examined either as outpatients or
at the first day of hospitalization. Nose swabs were taken from one
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Figure 1. SmaI macrorestriction patterns of S. aureus from patients with AD and from a control group. d, Strains from affected skin in AD, strains from
nasal swabs of AD patients; arabic numbers designate individual patients; (, strains from nasal swabs of healthy carriers; s, reference strains of the major clonal
groups of the species S. aureus.
anterior nare with sterile cotton tips. Skin swabs were obtained
from lesional skin of one volar forearm or further lesional areas and
applied on blood agar plates. The cultures were grown overnight
(37°C in 5% CO2). Colonies of S. aureus were subcultured on
sheep blood agar plates for identification by testing coagulase activity
and crystal violet type. Antibiotic susceptibility was assessed
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by microbroth dilution to determine minimal inhibitory concentration
according to the National Committee for Clinical Laboratory Standards
(1995). Staphylococcus aureus strains were phage typed using the Interna-
tional Phage Set and additional phages. Staphylococcus aureus strains were
assayed for production of staphylococcal enterotoxins (SEA-D) and
TSST-1 by the Latex agglutination test from Oxoid. Capacity for super-
antigen formation was assessed by polymerase chain reaction for toxin
genes as described previously (Johnson et al, 1991). Molecular population
analysis was performed by means of Serratia marcescens (SmaI) macro-
restriction analysis and r-RNA gene spacer patterns (Cuny and Witte,
1996). SmaI macrorestriction patterns were allotted to those of S. aureus
representative for clonal groups of these strains and stored in a databank
system. Agarose gels were image processed, and the molecular masses of
fragments were stored in the databank and analyzed for similarity as
previously described (Cuny and Witte, 1996). In 22 of 35 patients
(62.9%), S. aureus was isolated from one or more of the selected skin
areas. Twenty of the 22 S. aureus positive AD patients were also nasal
carriers. Eighteen patients revealed the same strain in skin colonization
and nasal mucosa. In four of 13 AD patients with negative skin but with
positive nose swabs, one strain produced staphylococcal enterotoxin C.
Eighteen of 60 (30%) of the healthy volunteers from the control group
revealed S. aureus colonization in the nasal cavity. Only 10 of 22 strains
(45%) of S. aureus isolated from AD patients were capable of producing
superantigens (enterotoxins A, B, C, TSST-1), as evidenced by detection
of the extracellular product and polymerase chain reaction for the corres-
ponding genetic determinants. This frequency corresponds with the
results for superantigen production of S. aureus strains isolated from eight
of 18 healthy carriers (44%). No predominance of a certain enterotoxin
or a clonal group of S. aureus was found. There was no correlation
between S. aureus strains capable of superantigen production and total
IgE or eosinophilic cationic protein plasma levels. Molecular typing of
S. aureus from AD patients by means of SmaI macrorestriction and
r-RNA gene spacer patterns revealed the same population structure as
demonstrated for S. aureus from nasal colonization. Data are given in the
similarity dendrogram (Fig 1). Staphylococcal colonization is regarded
as a constant phenomenon in AD patients and is reported to be independ-
ent of age and stages of skin inflammation. Previous studies revealed no
difference between children and adults concerning nasal colonization
with S. aureus and superantigen formation (Mochmann et al, 1981;
Richter et al, 1981). Hoeger et al (1992) found that the S. aureus coloniza-
tion rate observed in children with AD did not differ from that reported
for adult AD patients. Ogawa et al (1994), who report a comparative
study of staphylococcal flora on the skin surface of AD patients and
healthy subjects, did not find sex dependent differences in their patients.
The S. aureus carriage rate of 62.9% in our AD study group ranges at the
lower limit of those described by others (Bahkdi and Tranum-Jensen,
1991; McFadden et al, 1993; Monti et al, 1996). In 81.9% of our AD
patients identical S. aureus strains were isolated from nose and skin swabs,
as described previously (Goodyear et al, 1993). Several studies found a
relatively high rate of colonization with toxigenic S. aureus strains in AD
patients (64–100%) (Bahkdi and Tranum-Jensen, 1991; Leung et al, 1993;
McFadden et al, 1993), so that a causative role of superantigens in AD
was discussed. In our controlled study only 45% of strains from AD
patients were capable of producing superantigens (SEB, SEC, TSST-1)
as evidenced by detection of the extracellular product and polymerase
chain reaction for the corresponding genetic determinants; however, this
frequency does not exceed the number of S. aureus strains isolated from
healthy carriers (44%) capableof superantigenproduction.Nopredomin-
ance of a certain toxin was found in contrast to other authors, who
reported SEA (Hoeger et al, 1992) or TSST-1 (Jacobson et al, 1989) to
be the most commonly identified toxin. Staphylococcus aureus colonization
was proposed to be a stimulant for IgE production from in vitro experi-
ments (Neuber and Ko¨nig, 1992), especially the toxigenic ones. This
could not be confirmed in our in vivo study.
The prevalence of particular S. aureus strains in AD has been
suggested, but phage typing results did not support the existence of
any predominant biotype (Hoeger et al, 1992). This is in accordance
with our results. Molecular typing of S. aureus strains from AD patients
by means of SmaI macrorestriction and r-RNA gene spacer patterns
revealed the same population structure as S. aureus from nasal coloniza-
tion in normals. This indicates that the occurrence of S. aureus in AD
is not associated with a particular group of strains. Our results do not
support the hypothesis that skin colonization with S. aureus and
especially superantigen formation are an essential prerequisite in the
pathogenesis of AD. This study, however, does not exclude a possible
role of S. aureus superantigens in the acceleration of AD individual
clinical course in the case of skin colonization with superantigen
producing S. aureus.
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